Clinical Trial Update: Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the safety and efficacy of a combination Listeria-based GVAX immunotherapy in metastatic pancreatic cancer; results were posted in May 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Listeria-based GVAX immunotherapy

Snippet

Sponsor: Aduro Biotech, Inc. | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-08